Do you want to know more about the latest development in the Nordic Life Science industry? Get an update on HC Andersen Capital's view on valuation as well as presentations from listed Life Science companies and what their late-stage pipeline looks like by senior management at our Life Science seminar on 31 August.

We will release the agenda soon!

Disclaimer: HC Andersen Capital receives payment from the attending companies for a Digital IR/corporate visibility agreement.